Connection

Walter Ageno to Anticoagulants

Back to Details
This is a "connection" page, showing publications Walter Ageno has written about Anticoagulants.
Walter Ageno
Connection Strength
3.299
Anticoagulants
  1. A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism. Minerva Med. 2020 08; 111(4):370-372.
    View in: PubMed
    Score: 0.173
  2. Treatment of venous thromboembolism with tinzaparin in oncological patients. Minerva Med. 2019 Jun; 110(3):251-258.
    View in: PubMed
    Score: 0.172
  3. Breadth of complications of long-term oral anticoagulant care. Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):432-438.
    View in: PubMed
    Score: 0.166
  4. Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives. Hamostaseologie. 2018 May; 38(2):75-86.
    View in: PubMed
    Score: 0.160
  5. Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. Vasc Med. 2017 12; 22(6):529-540.
    View in: PubMed
    Score: 0.155
  6. Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? Yes. Intern Emerg Med. 2018 Oct; 13(7):1009-1013.
    View in: PubMed
    Score: 0.152
  7. Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation. Expert Opin Pharmacother. 2017 Sep; 18(13):1325-1332.
    View in: PubMed
    Score: 0.152
  8. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study. Vasc Med. 2017 12; 22(6):518-524.
    View in: PubMed
    Score: 0.151
  9. Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective. Pharmacol Res. 2017 Jun; 120:206-218.
    View in: PubMed
    Score: 0.148
  10. [The slow acceptance of new oral anticoagulants in Italy: a critical analysis of a problem]. G Ital Cardiol (Rome). 2017 Mar; 18(3):208-218.
    View in: PubMed
    Score: 0.147
  11. Direct oral anticoagulants for superficial-vein thrombosis. Lancet Haematol. 2017 03; 4(3):e95-e96.
    View in: PubMed
    Score: 0.147
  12. The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery? Curr Opin Anaesthesiol. 2010 Dec; 23(6):722-5.
    View in: PubMed
    Score: 0.095
  13. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials. Expert Rev Cardiovasc Ther. 2009 Jun; 7(6):569-76.
    View in: PubMed
    Score: 0.086
  14. Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study. Thromb Res. 2021 07; 203:138-141.
    View in: PubMed
    Score: 0.049
  15. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.048
  16. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost. 2020 Dec; 120(12):1654-1667.
    View in: PubMed
    Score: 0.048
  17. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? Semin Thromb Hemost. 2021 06; 47(4):338-340.
    View in: PubMed
    Score: 0.047
  18. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
    View in: PubMed
    Score: 0.046
  19. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study. Thromb Res. 2019 Nov; 183:28-32.
    View in: PubMed
    Score: 0.044
  20. The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients. Eur J Intern Med. 2019 04; 62:7-8.
    View in: PubMed
    Score: 0.042
  21. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thromb Haemost. 2019 Jan; 119(1):14-38.
    View in: PubMed
    Score: 0.042
  22. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Thromb Haemost. 2019 Feb; 119(2):319-327.
    View in: PubMed
    Score: 0.042
  23. Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis. Eur J Intern Med. 2019 03; 61:29-33.
    View in: PubMed
    Score: 0.041
  24. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis. Clin Transl Gastroenterol. 2018 08 15; 9(8):176.
    View in: PubMed
    Score: 0.041
  25. Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism. Int J Cardiol. 2018 Oct 15; 269:75-79.
    View in: PubMed
    Score: 0.040
  26. Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants? Intern Emerg Med. 2018 10; 13(7):1001-1004.
    View in: PubMed
    Score: 0.040
  27. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
    View in: PubMed
    Score: 0.040
  28. A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. JACC Cardiovasc Interv. 2018 03 12; 11(5):417-434.
    View in: PubMed
    Score: 0.039
  29. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thromb Res. 2018 04; 164:69-74.
    View in: PubMed
    Score: 0.039
  30. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism. Thromb Res. 2018 03; 163:128-131.
    View in: PubMed
    Score: 0.039
  31. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2017 12; 117(12):2406-2414.
    View in: PubMed
    Score: 0.039
  32. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study. Thromb Haemost. 2017 12; 117(12):2425-2434.
    View in: PubMed
    Score: 0.039
  33. Therapeutic Shifts in the Management of Cancer-Associated Thrombosis. Thromb Haemost. 2017 11; 117(11):2012.
    View in: PubMed
    Score: 0.039
  34. Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials. Eur Respir J. 2017 09; 50(3).
    View in: PubMed
    Score: 0.038
  35. Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL. Blood Transfus. 2018 09; 16(5):462-470.
    View in: PubMed
    Score: 0.038
  36. Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Intern Emerg Med. 2017 Oct; 12(7):923-934.
    View in: PubMed
    Score: 0.038
  37. An unusual case of neck pain in Hashimoto's thyroiditis. Intern Emerg Med. 2017 Sep; 12(6):817-819.
    View in: PubMed
    Score: 0.037
  38. The prevention and treatment of venous thromboembolism in pregnancy. Expert Rev Cardiovasc Ther. 2017 May; 15(5):397-402.
    View in: PubMed
    Score: 0.037
  39. NOACs for treatment of venous thromboembolism in clinical practice. Thromb Haemost. 2017 06 28; 117(7):1317-1325.
    View in: PubMed
    Score: 0.037
  40. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study. Thromb Res. 2017 Jul; 155:23-27.
    View in: PubMed
    Score: 0.037
  41. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res. 2017 May; 153:97-100.
    View in: PubMed
    Score: 0.037
  42. Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med. 2017 Apr; 12(3):387-406.
    View in: PubMed
    Score: 0.037
  43. Managing challenging patients with venous thromboembolism: a practical, case-based approach. Pol Arch Intern Med. 2017 Jan 04; 127(1):41-46.
    View in: PubMed
    Score: 0.036
  44. Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. Drug Saf. 2016 12; 39(12):1175-1187.
    View in: PubMed
    Score: 0.036
  45. Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications. Pol Arch Med Wewn. 2016 Aug 25; 126(7-8):552-61.
    View in: PubMed
    Score: 0.035
  46. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2776-86.
    View in: PubMed
    Score: 0.020
  47. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006 Jul; 130(1):172-5.
    View in: PubMed
    Score: 0.018
  48. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug; 18(8):1859-1865.
    View in: PubMed
    Score: 0.012
  49. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
    View in: PubMed
    Score: 0.012
  50. Hospital-based use of thromboprophylaxis in patients with COVID-19. Lancet. 2020 05 02; 395(10234):e75.
    View in: PubMed
    Score: 0.011
  51. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol. 2018 Feb; 35(2):142-146.
    View in: PubMed
    Score: 0.010
  52. Venous thromboembolism: Past, present and future. Thromb Haemost. 2017 06 28; 117(7):1219-1229.
    View in: PubMed
    Score: 0.009
  53. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.009
  54. Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide. Adv Ther. 2017 03; 34(3):620-637.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.